Epithelial and mesenchymal stem cells from the umbilical cord lining membrane

Cell Transplantation

Volumn 23, Issue 4-5, 2014, Pages 497-503

  Lim, Ivor J ^a   Phan, Toan Thang ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Antiaging; Cord lining; Regenerative medicine; Stem cells; Tissue repair and regeneration

Indexed keywords

ALBUMIN; ALPHA FETOPROTEIN; CYTOKERATIN 18; HERMES ANTIGEN; HLA E ANTIGEN; HLA G ANTIGEN; INDOLEAMINE 2,3 DIOXYGENASE; INTERCELLULAR ADHESION MOLECULE 1; MUCIN 1; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN; PROTEIN P63; REDUCED EXPRESSION PROTEIN 1; STAGE SPECIFIC EMBRYO ANTIGEN 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG; LEUKOCYTE ANTIGEN;

AMNION; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CORD LINING EPITHELIAL CELL; CORD LINING MESENCHYMAL CELL; ENZYME INDUCTION; EPITHELIAL STEM CELL; EPITHELIUM CELL; IMMUNOGENICITY; KERATINOCYTE; LIVER DEVELOPMENT; MESENCHYMAL STEM CELL; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; STEM CELL; UMBILICAL CORD; UMBILICAL CORD LINING MEMBRANE; ANIMAL; CYTOLOGY; HEART DISEASES; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; REGENERATIVE MEDICINE;

ANIMALS; ANTIGENS, CD; CELL DIFFERENTIATION; EPITHELIAL CELLS; HEART DISEASES; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; REGENERATIVE MEDICINE; UMBILICAL CORD;

EID: 84900418745     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368914X678346     Document Type: Review

References (46)

1. Ballen, K. K.; Gluckman, E.; Broxmeyer, H. E. Umbilical cord blood transplantation: The first 25 years and beyond. Blood 122(4):491-498;2013.
2. Benoit, E.; O'Donnell, T. F.; Patel, A. Safety and efficacy of autologous cell therapy in critical limb ischemia: A systematic review. Cell Transplant. 22:545-562; 2013.
3. Blanpain, C.; Fuchs, E. Epidermal stem cells of the skin. Annu. Rev. Cell Dev. Biol. 22:339-373; 2006.
4. Can, A.; Karahuseyinoglu, S. Concise review: Human umbilical cord stroma with regard to the source of fetusderived stem cells. Stem Cells 25:2886-2895; 2007.
5. Cheong, H. H.; Masilamani, J.; Phan, T. T.; Chan, S. Y. Cord lining progenitor cells: Potential in vitro adipogenesis model. Intl. J. Obes. 11:1625-1633; 2010.
6. Cheong, H. H.; Masilamani, J.; Chan, C. Y.; Phan, T. T. Metabolically functional hepatocyte-like cells from human umbilical cord lining epithelial cells. Assay Drug Dev. Technol. 11(2):130-138; 2013.
7. Choi, S.; Park, M.; Kim, J.; Hwang, S.; Park, S.; Lee, Y. The role of mesenchymal stem cells in the functional improvement of chronic renal failure. Stem Cells Dev. 18(3):521-529; 2009.
8. de Lima, M.; McNiece, I.; Robinson, S. N.; Munsell, M.; Eapen, M.; Horowitz, M.; Alousi, A.; Saliba, R.; McMannis, J. D.; Kaur, I.; Kebriaei, P.; Parmar, S.; Popat, U.; Hosing, C.; Champlin, R.; Bollard, C.; Molldrem, J. J.; Jones, R. B.; Nieto, Y.; Andersson, B. S.; Shah, N.; Oran, B.; Cooper, L. J.; Worth, L.; Qazilbash, M. H.; Korbling, M.; Rondon, G.; Ciurea, S.; Bosque, D.; Maewal, I.; Simmons, P. J.; Shpall, E. J. Cord-blood engraftment with ex vivo mesenchymal-cell coculture. N. Engl. J. Med. 367(24):2305-2315; 2012.
9. Deuse, T.; Stubbendorff, M.; Tang-Quan, K.; Phillips, N.; Kay, M. A.; Eiermann, T.; Phan, T. T.; Volk, H. D.; Reichenspurner, H.; Robbins, R. C.; Schrepfer, S. Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal cells. Cell Transplant. 20:655-667; 2011.
10. Dittmar, T.; Entschladen, F. Migratory properties of mesenchymal stem cells. Adv. Biochem. Eng. Biotechnol. 129: 117-136; 2013.
11. Franquesa, M.; Hoogduijn, M. J.; Reinders, M. E.; Eggenhofer, E.; Engela, A. U.; Mensah, F. K.; Torras, J.; Pileggi, A.; van Kooten, C.; Mahon, B.; Detry, O.; Popp, F. C.; Benseler, V.; Casiraghi, F.; Johnson, C.; Ancans, J.; Fillenberg, B.; dela Rosa, O.; Aran, J. M.; Roemeling-van Rhijn, M.; Pinxteren, J.; Perico N.; Gotti, E.; Christ, B.; Reading, J.; Introna, M.; Deans, R.; Shagidulin, M.; Farré, R.; Rambaldi, A.; Sanchez-Fueyo, A.; Obermajer, N.; Pulin, A.; Dor F. J., Portero-Sanchez, I.; Baan, C. C.; Rabelink, T. J.; Remuzzi, G.; Betjes, M. G.; Dahlke, M. H.; Grinyó, J. M.; MiSOT Study Group. Mesenchymal stem cells in solid organ transplantation (MiSOT) fourth meeting: Lessons learned from first clinical trials. Transplantation 96(3):234-238; 2013.
12. Gratwohl, A.; Baldomero, H.; Gratwohl, M.; Aljurf, M.; Bouzas, L. F.; Horowitz, M.; Kodera, Y.; Lipton, J.; Iida, M.; Pasquini, M. C.; Passweg, J.; Szer, J.; Madrigal, A.; Frauendorfer, K.; Niederwieser, D.; Worldwide Network of Blood and Marrow Transplantation (WBMT). Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: A global observational study. Haematologica 98(8):1282-1290; 2013.
13. Harris, D. T. Non-haematological uses of cord blood stem cells. Br. J. Haematol. 147(2):177-184; 2009.
14. Huang, L.; Wong, Y. P.; Gu, H.; Cai, Y. J.; Ho, Y.; Wang, C. C.; Leung, T. Y.; Burd, A. Stem cell-like properties of human umbilical cord lining epithelial cells and the potential for epidermal reconstitution. Cytotherapy 13(2):145-155; 2011.
15. Jeschke, M. G.; Gauglitz, G. G.; Phan, T. T. Umbilical cord lining membrane and Wharton's Jelly-derived mesenchymal stem cells: The similarities and differences. Open Tissue Eng. Regen. Med. J. 4:21-27; 2011.
16. Kenyon, K. R.; Tseng, S. C. Limbal autograft transplantation for ocular surface disorders. Ophthalmology 96(5): 709-723; 1989.
17. Kern, S.; Eichler, H.; Stoeve, J.; Klüter, H.; Bieback, K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord, or adipose tissue. Stem Cells 24:1294-1301; 2006.
18. Kita, K.; Gauglitz, G. G.; Phan, T. T.; Herndon, D. N.; Jeschke, M. G. Isolation and characterization of mesenchymal stem cells from the sub-amniotic human umbilical cord lining membrane. Stem Cells Dev. 19(4):491-501; 2010.
19. Le Blanc, K.; Frassoni, F.; Ball, L.; Locatelli, F.; Roelofs, H.; Lewis, I.; Lanino, E.; Sundberg, B.; Bernardo, M. E.; Remberger, M.; Dini, G.; Egeler, R. M.; Bacigalupo, A.; Fibbe, W.; Ringdén, O.; Developmental Committee of the European Group for Blood and Marrow Transplantation. Mesenchymal stem cells for the treatment of steroid-resistant, severe, acute graft-versus-host disease: A phase II study. Lancet 371:1579-1586; 2008.
20. Leistner, D. M.; Fischer-Rasokat, U.; Honold, J.; Seeger, F. H.; Schächinger, V.; Lehmann, R.; Martin, H.; Burck, I.; Urbich, C.; Dimmeler, S.; Zeiher, A. M.; Assmus, B. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): Final 5 year results suggest long-term safety and efficacy. Clin. Res. Cardiol. 100(10):925-934; 2011.
21. Lilyanna, S.; Martinez, E. C.; Vu, T. D.; Phan, T. T.; Kofidis, T. Cord lining-mesenchymal stem cells graft supplemented with an omental flap induces myocardial revascularization and ameliorates cardiac dysfunction in a rat model of chronic ischaemic heart failure. Tissue Eng. Part A 19(11-12):1303-1315; 2013.
22. Mader, E. K.; Butler, G.; Dowdy, S. C.; Mariani, A.; Knutson, K. L.; Federspiel, M. J.; Russell, S. J.; Galanis, E.; Dietz, A. B.; Peng, K. W. Optimizing patient derived mesenchymal stem cells as virus carriers for a phase I clinical trial in ovarian cancer. J. Transl. Med. 11:20; 2013.
23. Meisel, R. Zibert, A.; Laryea, M.; Göbel, U.; Däubener, W.; Dilloo, D. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-doxygenasemediated tryptophan degradation. Blood 103:4619-4621; 2004.
24. Mitchell, K. E.; Weiss, M. L.; Mitchell, B. M.; Martin, P.; Davis, D.; Morales, L.; Helwig, B.; Beerenstrauch, M.; Abou-Easa, K.; Hildreth, T.; Troyer, D.; Medicetty, S. Matrix cells from Wharton's Jelly form neurons and glia. Stem Cells 21:50-60; 2003.
25. Morigi, M.; Imberti, B.; Zoja, C.; Corna, D.; Tomasoni, S.; Abbate, M.; Rottoli, D.; Angioletti, S.; Benigni, A.; Perico, N.; Alison, M.; Remuzzi, G. Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J. Am. Soc. Nephrol. 15:1794-1804; 2004.
26. Navarro, F.; Llano, M.; Bellón, T.; Colonna, M.; Geraghty, D. E.; López-Botet, M. The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells. Eur. J. Immunol. 29: 277-283; 1999.
27. Parolini, O.; Alviano, F.; Bagnara, G. P.; Bilic, G.; Bühring, H. J.; Evangelista, M.; Hennerbichler, S.; Liu, B.; Magatti, M.; Mao, N.; Miki, T.; Marongiu, F.; Nakajima, H.; Nikaido, T.; Portmann-Lanz, C. B.; Sankar, V.; Soncini, M.; Stadler, G.; Surbek, D.; Takahashi, T. A.; Redl, H.; Sakuragawa, N.; Wolbank, S.; Zeisberger, S.; Zisch, A.; Strom, S. C. Concise review: Isolation and characterization of cells from human term placenta: Outcome of the first international workshop on placenta derived stem cells. Stem Cells 26:300-311; 2008.
28. Pellegrini, G.; Traverso, C. E.; Franzi, A. T.; Zingirian, M.; Cancedda, R.; De Luca, M. Long term restoration of damaged corneal surfaces with autologous cultivated corneal epithelium. Lancet 349(9057):990-993; 1997.
29. Perin, E. C.; Willerson, J. T.; Pepine, C. J.; Henry, T. D.; Ellis, S. G.; Zhao, D. X.; Silva, G. V.; Lai, D.; Thomas, J. D.; Kronenberg, M. W.; Martin, A. D.; Anderson, R. D.; Traverse, J. H.; Penn, M. S.; Anwaruddin, S.; Hatzopoulos, A. K.; Gee, A. P.; Taylor, D. A.; Cogle, C. R.; Smith, D.; Westbrook, L.; Chen, J.; Handberg, E.; Olson, R. E.; Geither, C.; Bowman, S.; Francescon, J.; Baraniuk, S.; Piller, L. B.; Simpson, L. M.; Loghin, C.; Aguilar, D.; Richman, S.; Zierold, C.; Bettencourt, J.; Sayre, S. L.; Vojvodic, R. W.; Skarlatos, S. I.; Gordon, D. J.; Ebert, R. F.; Kwak, M.; Moyé, L. A.; Simari, R. D.; Cardiovascular Cell Therapy Research Network (CCTRN). Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: The FOCUSCCTRN trial. JAMA 307(16):1717-1726; 2012.
30. Peters, R.; Wolf, M. J.; van den Broek, M.; Nuvolone, M.; Dannenmann, S.; Stieger, B.; Rapold, R.; Konrad, D.; Rubin, A.; Bertino, J. R.; Aguzzi, A.; Heikenwalder, M.; Knuth, A. K. Efficient generation of multipotent mesenchymal stem cells from umbilical cord blood in stroma-free liquid culture. PLOS One 5(12):e15689; 2010.
31. Pittenger, M. F.; Mackay, A. M.; Beck, S. C.; Jaiswal, R. K.; Douglas, R.; Mosca, J. D.; Moorman, M. A.; Simonetti, D. W.; Craig, S.; Marshak, D. R. Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147; 1999.
32. Pittenger, M. F.; Martin, B. J. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ. Res. 95(1): 9-20; 2004.
33. Rao, M. S.; Mattson, M. P. Stem cells and aging: Expanding the possibilities. Mech. Ageing Dev. 122(7):713-734; 2001.
34. Reza, H. M.; Ng, B.Y.;Gimeno, F. L.; Phan, T. T.; Ang, L. P. Umbilical cord lining stem cells as a novel and promising source for ocular surface regeneration. Stem Cell Rev. 7(4): 935-947; 2011.
35. Reza, H. M.; Ng, B.Y.; Phan, T. T.; Tan, D. T.; Beuerman, R. W.; Ang, L. D. Characterization of a novel umbilical cord lining cell with CD227 positivity and unique pattern of P63 expression and function. Stem Cell Rev. 7(3):624-638; 2011.
36. Rizvi, A.; Wong, M. H. Epithelial stem cells and their niche: There's no place like home. Stem Cells 23:150-165; 2005.
37. Romanov, Y. A.; Svintsitskaya, V. A.; Smirnov, V. N. Searching for alternative sources of postnatal human mesenchymal stem cells: Candidate MSC-like cells from umbilical cord. Stem Cells 21:105-110; 2003.
38. Rosamond, W.; Flegal, K.; Friday, G.; Furie, K.; Go, A.; Greenlund, K.; Haase, N.; Ho, M.; Howard, V.; Kissela, B.; Kittner, S.; Lloyd-Jones, D.; McDermott, M.; Meigs, J.; Moy, C.; Nichol, G.; O'Donnell, C. J.; Roger, V.; Rumsfeld, J.; Sorlie, P.; Steinberger, J.; Thom, T.; Wasserthiel-Smoller, S.; Hong, Y.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2007 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 115(5):e69-171; 2007.
39. Ruetze, M.; Gallinat, S.; Lim, I. J.; Chow, E.; Phan, T. T.; Staeb, F.; Wenck, H.; Deppert, W.; Knott, A. Common features of umbilical cord epithelial cells and epidermal keratinocytes. J. Dermatol. Sci. 50:227-231; 2008.
40. Sheridan, C. Cardiac stem cell therapies inch toward clinical litmus test. Nat. Biotech. 31(1): 5-6; 2013.
41. Shi, M.; Zhang, Z.; Xu, R.; Lin, H.; Fu, J.; Zou, Z.; Zhang, A.; Shi, J.; Chen, L.; Lv, S.; He, W.; Geng, H.; Jin, L.; Liu, Z.; Wang, F. S. Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients. Stem Cells Transl. Med. 1(10):725-731; 2012.
42. Sivalingam, J.; Krishnan, S.; Ng, W. H.; Lee, S. S.; Phan, T. T.; Kon, O. L. Biosafety assessment of site-directed transgene integration in human umbilical cord-lining cells. Mol. Ther. 7:1346-1356; 2010.
43. Stolzing, A.; Scutt, A. Age-related impairment of mesenchymal progenitor cell function. Aging Cell 5:213-224; 2006.
44. Stubbendorff, M.; Deuse, T.; Hua, X.; Phan, T. T.; Bieback, K.; Atkinson, K.; Eiermann, T. H.; Velden, J.; Schröder, C.; Reichenspurner, H.; Robbins, R. C.; Volk, H. D.; Schrepfer, S. Immunological properties of extraembryonic human mesenchymal stromal cells derived from gestational tissue. Stem Cells Dev. 22(19):2619-2629; 2013.
45. Yang, W. Z.; Zhang, Y.; Wu, F.; Min, W. P.; Minev, B.; Zhang, M.; Luo, X. L.; Ramos, F.; Ichim, T. E.; Riordan, N. H.; Hu, X. Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditions. J. Transl. Med. 8:75; 2010.
46. Zhou, Y.; Gan, S. U.; Lin, G.; Lim, Y. T.; Masilamani, J.; Mustafa, F. B.; Phua, M. L.; Rivino, L.; Phan, T. T.; Lee, K. O.; Calne, R.; MacAry, P. A. Characterization of human umbilical cord-lining derived epithelial cells and transplantation potential. Cell Transplant. 20:1827-1841; 2011.